The expression of interleukin-12 is increased by MAP kinase phosphatase-1 through a mechanism related to interferon regulatory factor 1

Molecular Immunology

Volumn 51, Issue 2, 2012, Pages 219-226

  Korhonen, Riku ^a   Huotari, Noora ^a   Hömmö, Tuija ^a   Leppänen, Tiina ^a   Moilanen, Eeva ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

IL 12; IRF1; Macrophage; MKP 1; P38 MAPK

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DORAMAPIMOD; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12P40; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME DEFICIENCY; ENZYME INHIBITION; GENE SILENCING; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE KNOCKDOWN TECHNIQUES; INTERFERON REGULATORY FACTOR-1; INTERLEUKIN-12; MACROPHAGES; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 84860378324     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.03.019     Document Type: Article

References (50)

1. Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., Saklatvala J., Clark A.R. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 2006, 203:1883-1889.
2. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
3. Boutros T., Chevet E., Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol. Rev. 2008, 60:261-310.
4. Burnette B.L., Selness S., Devraj R., Jungbluth G., Kurumbail R., Stillwell L., Anderson G., Mnich S., Hirsch J., Compton R., De Ciechi P., Hope H., Hepperle M., Keith R.H., Naing W., Shieh H., Portanova J., Zhang Y., Zhang J., Leimgruber R.M., Monahan J. SD0006: a potent, selective and orally available inhibitor of p38 kinase. Pharmacology 2009, 84:42-60.
5. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2274-2279.
6. Decker T., Stockinger S., Karaghiosoff M., Muller M., Kovarik P. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 2002, 109:1271-1277.
7. Dixon W.G., Kezouh A., Bernatsky S., Suissa S. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann. Rheum. Dis. 2011, 70:956-960.
8. Dorfman K., Carrasco D., Gruda M., Ryan C., Lira S.A., Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 1996, 13:925-931.
9. Franklin C.C., Kraft A.S. Conditional Expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 1997, 272:16917-16923.
10. Gri G., Savio D., Trinchieri G., Ma X. Synergistic regulation of the human interleukin-12 p40 promoter by NF(B and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages. J. Biol. Chem. 1998, 273:6431-6438.
11. Grijalva C.G., Kaltenbach L., Arbogast P.G., Mitchel E.F., Griffin M.R. Initiation of rheumatoid arthritis treatments and the risk of serious infections. Rheumatology 2010, 49:82-90.
12. Hämäläinen M., Korhonen R., Moilanen E. Calcineurin inhibitors down-regulate iNOS expression by destabilising mRNA. Int. Immunopharmacol. 2009, 9:159-167.
13. -/- mice in polymicrobial peritonitis models. Immunology 2010, 131:395-404.
14. Hammer M., Mages J., Dietrich H., Servatius A., Howells N., Cato A.C.B., Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 2006, 203:15-20.
15. Hope H.R., Anderson G.D., Burnette B.L., Compton R.P., Devraj R.V., Hirsch J.L., Keith R.H., Li X., Mbalaviele G., Messing D.M., Saabye M.J., Schindler J.F., Selness S.R., Stillwell L.I., Webb E.G., Zhang J., Monahan J.B. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation. J. Pharmacol. Exp. Ther. 2009, 331:882-895.
16. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
17. Huang G., Wang Y., Shi L., Kanneganti T., Chi H. Signaling by the phosphatase MKP-1 in dendritic cells imprints distinct effector and regulatory T cell fates. Immunity 2011, 35:45-58.
18. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
19. Kano S., Sato K., Morishita Y., Vollstedt S., Kim S., Bishop K., Honda K., Kubo M., Taniguchi T. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat. Immunol. 2008, 9:34-41.
20. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001, 20:7108-7116.
21. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989, 170:827-845.
22. Korhonen R., Kankaanranta H., Lahti A., Lähde M., Knowles R.G., Moilanen E. Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin. Biochem. J. 2001, 354:351-358.
23. Korhonen R., Turpeinen T., Taimi V., Nieminen R., Goulas A., Moilanen E. Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase. Mol. Immunol. 2011, 48:2059-2068.
24. Kotlyarov A., Neininger A., Schubert C., Eckert R., Birchmeier C., Volk H.D., Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1999, 1:94-97.
25. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
26. Liu Y., Shepherd E.G., Nelin L.D. MAPK phosphatases: regulating the immune response. Nat. Rev. Immunol. 2007, 7:202-212.
27. Lohoff M., Ferrick D., Mittrucker H.W., Duncan G.S., Bischof S., Rollinghoff M., Mak T.W. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997, 6:681-689.
28. Lu H.T., Yang D.D., Wysk M., Gatti E., Mellman I., Davis R.J., Flavell R.A. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 1999, 18:1845-1857.
29. Lyakh L., Trinchieri G., Provezza L., Carra G., Gerosa F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 2008, 226:112-131.
30. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 1993, 177:1199-1204.
31. Maruyama S., Sumita K., Shen H., Kanoh M., Xu X., Sato M., Matsumoto M., Shinomiya H., Asano Y. Identification of IFN regulatory factor-1 binding site in IL-12 p40 gene promoter. J. Immunol. 2003, 170:997-1001.
32. Murphy T., Cleveland M., Kulesza P., Magram J., Murphy K. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell Biol. 1995, 15:5258-5267.
33. Nieminen R., Korhonen R., Moilanen T., Clark A.R., Moilanen E. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs. Arthritis Rheum. 2010, 62:1650-1659.
34. Noubade R., Milligan G., Zachary J.F., Blankenhorn E.P., del Rio R., Rincon M., Teuscher C. Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J. Clin. Invest. 2007, 117:3507-3518.
35. Rincon M., Enslen H., Raingeaud J., Recht M., Zapton T., Su M.S., Penix L.A., Davis R.J., Flavell R.A. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 1998, 17:2817-2829.
36. Rincón M., Davis R.J. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 2009, 228:212-224.
37. Salkowski C.A., Kopydlowski K., Blanco J., Cody M.J., McNally R., Vogel S.N. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 1999, 163:1529-1536.
38. Salojin K.V., Owusu I.B., Millerchip K.A., Potter M., Platt K.A., Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 2006, 176:1899-1907.
39. Schroder K., Spille M., Pilz A., Lattin J., Bode K.A., Irvine K.M., Burrows A.D., Ravasi T., Weighardt H., Stacey K.J., Decker T., Hume D.A., Dalpke A.H., Sweet M.J. Differential effects of CpG DNA on IFN-β induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages. J. Immunol. 2007, 179:3495-3503.
40. Shipp L.E., Lee J.V., Yu C., Pufall M., Zhang P., Scott D.K., Wang J. Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids. PLoS ONE 2010, 5:e13754.
41. Szczepankiewicz B.G., Kosogof C., Nelson L.T.J., Liu G., Liu B., Zhao H., Serby M.D., Xin Z., Liu M., Gum R.J., Haasch D.L., Wang S., Clampit J.E., Johnson E.F., Lubben T.H., Stashko M.A., Olejniczak E.T., Sun C., Dorwin S.A., Haskins K., Abad-Zapatero C., Fry E.H., Hutchins C.W., Sham H.L., Rondinone C.M., Trevillyan J.M. Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity†. J. Med. Chem. 2006, 49:3563-3580.
42. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., Suzuki G., Mitsuyama M., Shin E.H., Kojima S., Taniguchi T., Asano Y. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997, 6:673-679.
43. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 2001, 19:623-655.
44. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
45. Turpeinen T., Nieminen R., Taimi V., Heittola T., Sareila O., Clark A.R., Moilanen E., Korhonen R. Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinase. Mediators Inflamm. 2011, 2011:127587.
46. Turpeinen T., Nieminen R., Moilanen E., Korhonen R. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells. J. Pharmacol. Exp. Ther. 2010, 333:310-318.
47. Yang Z., Zhang X., Darrah P.A., Mosser D.M. The regulation of Th1 responses by the p38 MAPK. J. Immunol. 2010, 185:6205-6213.
48. Yoshimoto T., Kojima K., Funakoshi T., Endo Y., Fujita T., Nariuchi H. Molecular cloning and characterization of murine IL-12 genes. J. Immunol. 1996, 156:1082-1088.
49. Zhao Q., Wang X., Nelin L.D., Yao Y., Matta R., Manson M.E., Baliga R.S., Meng X., Smith C.V., Bauer J.A., Chang C., Liu Y. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 2006, 203:131-140.
50. Zhu J., Wu X., Goel S., Gowda N.M., Kumar S., Krishnegowda G., Mishra G., Weinberg R., Li G., Gaestel M., Muta T., Gowda D.C. MAPK-activated protein kinase 2 differentially regulates Plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-α and interleukin-12 in macrophages. J. Biol. Chem. 2009, 284:15750-15761.